{"id":230784,"date":"2025-10-28T20:59:17","date_gmt":"2025-10-28T20:59:17","guid":{"rendered":"https:\/\/www.newsbeep.com\/uk\/230784\/"},"modified":"2025-10-28T20:59:17","modified_gmt":"2025-10-28T20:59:17","slug":"lilly-deploys-pharmas-largest-most-powerful-ai-factory-for-drug-discovery-using-nvidia-blackwell-based-dgx-superpod","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/uk\/230784\/","title":{"rendered":"Lilly Deploys Pharma\u2019s Largest, Most Powerful AI Factory for Drug Discovery Using NVIDIA Blackwell-Based DGX SuperPOD"},"content":{"rendered":"<p>\tLilly Deploys Pharma\u2019s Largest, Most Powerful AI Factory for Drug Discovery Using NVIDIA Blackwell-Based DGX SuperPOD | NVIDIA Blog<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2025\/08\/1x1-00000000.png\" width=\"1\" height=\"1\" style=\"display:none;\" alt=\"country_code\"\/><\/p>\n<p>\t<a class=\"skip-link screen-reader-text\" href=\"#content\">Skip to content<\/a><\/p>\n<p>\n\t\t\t\t\tBuilt with over 1,000 NVIDIA Blackwell Ultra GPUs, the AI factory will support modern scientific research using foundation models, as well as physical and agentic AI.\t\t\t\t<\/p>\n<p>\n\t\tYour browser does not support the video tag.\t<\/p>\n<p>Lilly, a pioneer in medicine, is deploying the largest, most powerful AI factory wholly owned and operated by a pharmaceutical company \u2014 the world\u2019s first <a href=\"https:\/\/www.nvidia.com\/en-us\/data-center\/dgx-superpod\/\" rel=\"nofollow noopener\" target=\"_blank\">NVIDIA DGX SuperPOD<\/a> with <a href=\"https:\/\/www.nvidia.com\/en-us\/data-center\/dgx-b300\" rel=\"nofollow noopener\" target=\"_blank\">DGX B300 systems<\/a>.<\/p>\n<p>Built with 1,016 NVIDIA Blackwell Ultra GPUs and announced today at NVIDIA GTC Washington, D.C., the AI factory is poised to compress drug discovery timelines and enable accelerated breakthroughs in genomics, personalized medicine and molecular design at industrial scale.<\/p>\n<p>\tYour browser does not support the video tag.<\/p>\n<p>\t\t\tVideo courtesy of Lilly.\n\t<\/p>\n<p>The AI factory will be used to train large scale biomedical foundation and frontier models for drug discovery and development. Select models will be made available on Lilly TuneLab \u2014 an AI and machine learning platform that provides biotech companies with access to drug discovery models built on $1 billion worth of Lilly\u2019s proprietary data.<\/p>\n<p>TuneLab is now the first drug discovery platform to offer Lilly models and <a href=\"https:\/\/github.com\/nvidia\/clara\" rel=\"nofollow noopener\" target=\"_blank\">NVIDIA Clara<\/a> open foundation models for healthcare and life sciences, further expanding AI access for the biotech ecosystem.<\/p>\n<p>TuneLab uses a federated learning infrastructure built on <a href=\"https:\/\/developer.nvidia.com\/flare\" rel=\"nofollow noopener\" target=\"_blank\">NVIDIA FLARE<\/a>, which enables biotechs to tap into powerful proprietary AI models while keeping their own data private and separate from other users. As more companies participate, the models improve, benefitting all users.<\/p>\n<p>\u201cOur foundation models are spawning new possibilities for our chemists, helping them uncover new motifs and configurations of atoms that were out of reach with traditional methods,\u201d said Thomas Fuchs, chief AI officer at Lilly. \u201cAI gives us the means to accelerate progress toward both developing and delivering better, more personalized and targeted medicines.\u201d<\/p>\n<p>\t\t\t<img width=\"2048\" height=\"819\" src=\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2025\/10\/fuchs-pulled-quote-1-scaled.jpg\" class=\"full-width-layout__image\" alt=\"\u201cAI gives us the means to accelerate progress toward both developing and delivering better, more personalized and targeted medicines,\u201d said Thomas Fuchs, chief AI officer at Lilly.\" loading=\"lazy\"  decoding=\"async\" \/>\t<\/p>\n<p>The AI factory is powered by NVIDIA\u2019s full-stack AI factory architecture offered with NVIDIA DGX SuperPOD \u2014 including accelerated computing, <a href=\"https:\/\/www.nvidia.com\/en-us\/networking\/spectrumx\/\" rel=\"nofollow noopener\" target=\"_blank\">NVIDIA Spectrum-X<\/a> Ethernet networking and optimized AI software. This provides a secure, scalable, purpose-built platform for the highly regulated healthcare and life sciences industries.<\/p>\n<p><a href=\"https:\/\/www.nvidia.com\/en-us\/data-center\/mission-control\/\" rel=\"nofollow noopener\" target=\"_blank\">NVIDIA Mission Control<\/a> software allows Lilly to manage its DGX SuperPOD, orchestrate workloads, monitor performance and automate AI operations securely and efficiently across more than 1,000 GPUs.<\/p>\n<p>\tAI Applied Across Drug Discovery, Precision Medicine<\/p>\n<p>Lilly scientists can use the AI factory to analyze entire genome sequences, predict patient outcomes and explore multitudes of biochemical possibilities.<\/p>\n<p>\u201cIn our 150 years, Lilly has always closely connected science and technology,\u201d said Diogo Rau, executive vice president and chief information and digital officer at Lilly. \u201cIf you focus only on science, you\u2019re just going to have an experiment, a paper or a treatment \u2014 but if you bring together science and technology, like the accelerated compute we\u2019re getting through this AI factory, you can reach a massive scale to bring the treatment to millions of people.\u201d<\/p>\n<p>\t\t\t<img width=\"2048\" height=\"819\" src=\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2025\/10\/rau-pulled-quote-1-scaled.jpg\" class=\"full-width-layout__image\" alt=\"\u201cIf you bring together science and technology \u2026 you can reach a massive scale to bring the treatment to millions of people,\u201d said Diogo Rau, executive vice president and chief information and digital officer at Lilly.\" loading=\"lazy\"  decoding=\"async\" \/>\t<\/p>\n<p>Using the <a href=\"https:\/\/www.nvidia.com\/en-us\/clara\/biopharma\/\" rel=\"nofollow noopener\" target=\"_blank\">NVIDIA BioNeMo<\/a> platform, Lilly can train AI models that combine the learnings of millions of past experiments with public research to generate and test new antibodies, nanobodies and novel molecules with greater accuracy and speed than ever.<\/p>\n<p>The AI factory can also be applied to help discover new biomarkers and design gene therapies for degenerative conditions, Fuchs said.<\/p>\n<p>Your browser does not support HTML5 video.<\/p>\n<p>\t\t\tVideo courtesy of Lilly.\n\t<\/p>\n<p>And the impact extends beyond drug discovery.<\/p>\n<p>Using the AI factory, the company can build <a href=\"https:\/\/www.nvidia.com\/en-us\/glossary\/large-language-models\/\" rel=\"nofollow noopener\" target=\"_blank\">large language models<\/a> that accelerate clinical trials by helping with medical writing and other internal workflows.<\/p>\n<p>And combined with the open-source <a href=\"https:\/\/monai.io\/\" rel=\"nofollow noopener\" target=\"_blank\">MONAI<\/a> framework, the AI factory can accelerate Lilly\u2019s imaging-based research in precision medicine. Deep learning on massive imaging datasets can reduce processing time from months to days, allowing for quicker, more personalized treatments.<\/p>\n<p>\tResearch and Biomanufacturing With Physical and Agentic AI<\/p>\n<p>The AI factory is poised to enhance Lilly\u2019s capacity to manufacture high-demand medications and strengthen supply chain reliability, including through the use of <a href=\"https:\/\/www.nvidia.com\/en-us\/glossary\/generative-physical-ai\/\" rel=\"nofollow noopener\" target=\"_blank\">physical AI<\/a>.<\/p>\n<p>\tYour browser does not support the video tag.<\/p>\n<p>\t\t\tVideo courtesy of Lilly\n\t<\/p>\n<p>With technologies like the <a href=\"https:\/\/www.nvidia.com\/en-us\/omniverse\/\" rel=\"nofollow noopener\" target=\"_blank\">NVIDIA Omniverse<\/a> platform and <a href=\"https:\/\/www.nvidia.com\/en-us\/data-center\/products\/rtx-pro-server\/\" rel=\"nofollow noopener\" target=\"_blank\">NVIDIA RTX PRO Servers<\/a>, the pharma company can create digital twins of its manufacturing lines to model, stress-test and optimize entire supply chains before making physical changes in the real world.<\/p>\n<p>Digital twins can increase production safety while accelerating quality assurance and other biomanufacturing operations, ultimately getting medicines to patients faster.<\/p>\n<p>Lilly also uses robots in its factories for quality inspection and transport of goods \u2014 such as medicines and treatment components like injectors \u2014 optimizing operations and keeping production lines up and running.<\/p>\n<p>\tYour browser does not support the video tag.<\/p>\n<p>\t\t\tVideo courtesy of Lilly.\n\t<\/p>\n<p>\u201cMachinery downtime can mean significant delays in getting patients the medicines they rely on,\u201d Fuchs said. \u201cWe\u2019re focused on optimizing systems and driving toward peak performance using AI.\u201d<\/p>\n<p>With the <a href=\"https:\/\/developer.nvidia.com\/isaac\" rel=\"nofollow noopener\" target=\"_blank\">NVIDIA Isaac<\/a> platform, Lilly can deploy intelligent robotics to modernize therapeutics production and support the workforce. <a href=\"https:\/\/developer.nvidia.com\/isaac\/sim\" rel=\"nofollow noopener\" target=\"_blank\">NVIDIA Isaac Sim<\/a>, for example, lets developers simulate and test AI-driven robotics solutions that can be adapted to pharma workflows.<\/p>\n<p>Plus, using <a href=\"https:\/\/www.nvidia.com\/en-us\/ai-data-science\/products\/nemo\/\" rel=\"nofollow noopener\" target=\"_blank\">NVIDIA NeMo<\/a> software, Lilly can create AI agents that can reason, plan and act across digital and physical labs, with the goal of helping to generate new molecules, design treatments in silico and test them in vitro.<\/p>\n<p>\u201cAI agents can work 24\/7 and explore ideas that humans might not have the time or capacity to experiment with,\u201d Rau said. \u201cAt the end of the day, it\u2019s all about human learning \u2014 not machine learning. Machines are helping make humans smarter by stimulating new ideas for new molecules.\u201d<\/p>\n<p>\t\t\t<img width=\"2048\" height=\"819\" src=\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2025\/10\/rau-pulled-quote-2-scaled.jpg\" class=\"full-width-layout__image\" alt=\"\u201cMachines are helping make humans smarter by stimulating new ideas for new molecules,\u201d said Diogo Rau, executive vice president and chief information and digital officer at Lilly.\" loading=\"lazy\"  decoding=\"async\" \/>\t<\/p>\n<p>\tFueling US Leadership and Economic Growth<\/p>\n<p>Lilly is already ranked the No. 1 most AI-ready pharma company, according to <a href=\"https:\/\/www.cbinsights.com\/research\/ai-readiness-index-pharma-2025\/\" rel=\"nofollow noopener\" target=\"_blank\">CB Insights<\/a>, cited as having the highest AI innovation score and the most partnerships with AI-enabled drug development platforms in the industry.<\/p>\n<p>Now, the new AI factory positions Lilly as an AI-native U.S. and global pharma leader.<\/p>\n<p>The leap in computing power is immense.<\/p>\n<p>In 1992, Lilly\u2019s Cray supercomputer was the pinnacle of scientific computing. Today, a single NVIDIA Blackwell Ultra GPU in the new AI factory contains the power of approximately 7 million Cray systems.<\/p>\n<p>And since the AI factory comprises 1,016 Blackwell Ultra GPUs, it delivers over 9,000 petaflops of AI performance. This means it can do over 9 quintillion math problems every second.<\/p>\n<p>\t\t\t<img width=\"2048\" height=\"819\" src=\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2025\/10\/blackwell-ai-factory-infographic-scaled.jpg\" class=\"full-width-layout__image\" alt=\"Infographic that says: \u201c1,016 NVIDIA Blackwell Ultra GPUs, 9,000 petaflops of AI performance, 9 quintillion math problems per second.\u201d\" loading=\"lazy\"  decoding=\"async\" \/>\t<\/p>\n<p>The collaboration with NVIDIA is a cornerstone of Lilly\u2019s innovation blueprint, building on its $50 billion commitment to expanding its U.S. manufacturing and R&amp;D footprint. This commitment includes four new facilities and a proposed $4.5 billion lab in Indiana, called the <a href=\"https:\/\/thefoundrypartners.com\/\" rel=\"nofollow noopener\" target=\"_blank\">Lilly Medicine Foundry<\/a>, for advanced manufacturing and drug development.<\/p>\n<p>Combined, these initiatives are poised to create 13,000 high-wage manufacturing and construction jobs. The Medicine Foundry will also create approximately 500 new jobs, including for engineers, scientists, operations personnel and lab technicians.<\/p>\n<\/p>\n<p>Turning proprietary data into intelligence supports Lilly in helping patients while creating economic value and fueling U.S. leadership in advanced manufacturing and regulated industries.<\/p>\n<p>\u201cWe\u2019re just scratching the surface of what\u2019s possible with AI in medicine design and development,\u201d Fuchs said. \u201cThis new AI factory and our collaborations across the whole biotech community will fundamentally change how we design, build and develop medicines.\u201d<\/p>\n<p>\t\t\t<img width=\"2048\" height=\"819\" src=\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2025\/10\/fuchs-pulled-quote-2-scaled.jpg\" class=\"full-width-layout__image\" alt=\"\u201cWe\u2019re just scratching the surface of what\u2019s possible with AI in medicine design and development,\u201d said Thomas Fuchs, chief AI officer at Lilly.\" loading=\"lazy\"  decoding=\"async\" \/>\t<\/p>\n<p>Related News<\/p>\n<p>\t<a href=\"https:\/\/blogs.nvidia.com\/blog\/nvidia-gtc-washington-dc-2025-news\/\" aria-hidden=\"true\" tabindex=\"-1\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\t<img width=\"960\" height=\"640\" src=\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2025\/10\/keynoterecap-featuredimag-updated-960x640.jpg\" class=\"attachment-medium size-medium\" alt=\"\" aria-hidden=\"true\" loading=\"lazy\" decoding=\"async\"  \/>\t<\/a><\/p>\n<p>\t<a id=\"related-news-post-title-86223\" class=\"full-width-layout__news-post-title\" href=\"https:\/\/blogs.nvidia.com\/blog\/nvidia-gtc-washington-dc-2025-news\/\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\tNVIDIA GTC Washington, DC: Live Updates on What\u2019s Next in AI\t<\/a><\/p>\n<p>\t\tMonday, Oct. 27, 12:30 p.m. ET How Medium-Sized Cities Are Tackling AI Readiness \ud83d\udd17 A panel discussion today at GTC Washington, D.C., highlighted a public-private initiative to invigorate the economy&#8230;    <a class=\"read-more\" aria-hidden=\"true\" tabindex=\"-1\" href=\"https:\/\/blogs.nvidia.com\/blog\/nvidia-gtc-washington-dc-2025-news\/\" rel=\"nofollow noopener\" target=\"_blank\">\t\tRead Article            <\/a>\t<\/p>\n<p>\t<a href=\"https:\/\/blogs.nvidia.com\/blog\/ai-physics-aerospace-automotive-design-engineering\/\" aria-hidden=\"true\" tabindex=\"-1\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\t<img width=\"960\" height=\"540\" src=\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2025\/10\/CAE-Image-960x540.jpg\" class=\"attachment-medium size-medium\" alt=\"\" aria-hidden=\"true\" loading=\"lazy\" decoding=\"async\"  \/>\t<\/a><\/p>\n<p>\t<a id=\"related-news-post-title-86420\" class=\"full-width-layout__news-post-title\" href=\"https:\/\/blogs.nvidia.com\/blog\/ai-physics-aerospace-automotive-design-engineering\/\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\tNVIDIA AI Physics Transforms Aerospace and Automotive Design, Accelerating Engineering by 500x\t<\/a><\/p>\n<p>\t\tLeading technology companies in aerospace and automotive are accelerating their engineering design processes with the NVIDIA DoMINO NIM microservice, part of the NVIDIA PhysicsNeMo AI physics framework. By integrating GPU-accelerated&#8230;    <a class=\"read-more\" aria-hidden=\"true\" tabindex=\"-1\" href=\"https:\/\/blogs.nvidia.com\/blog\/ai-physics-aerospace-automotive-design-engineering\/\" rel=\"nofollow noopener\" target=\"_blank\">\t\tRead Article            <\/a>\t<\/p>\n<p>\t<a href=\"https:\/\/blogs.nvidia.com\/blog\/economic-development-us\/\" aria-hidden=\"true\" tabindex=\"-1\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\t<img width=\"960\" height=\"640\" src=\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2025\/10\/DSCF7830_V2-1-960x640.jpg\" class=\"attachment-medium size-medium\" alt=\"\" aria-hidden=\"true\" loading=\"lazy\" decoding=\"async\"  \/>\t<\/a><\/p>\n<p>\t<a id=\"related-news-post-title-86513\" class=\"full-width-layout__news-post-title\" href=\"https:\/\/blogs.nvidia.com\/blog\/economic-development-us\/\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\tFueling Economic Development Across the US: How NVIDIA Is Empowering States, Municipalities and Universities to Drive Innovation\t<\/a><\/p>\n<p>\t\tTo democratize access to AI technology nationwide, AI education and deployment can\u2019t be limited to a few urban tech hubs \u2014 it must reach every community, university and state. That\u2019s&#8230;    <a class=\"read-more\" aria-hidden=\"true\" tabindex=\"-1\" href=\"https:\/\/blogs.nvidia.com\/blog\/economic-development-us\/\" rel=\"nofollow noopener\" target=\"_blank\">\t\tRead Article            <\/a>\t<\/p>\n<p>\t<a href=\"https:\/\/blogs.nvidia.com\/blog\/naval-postgraduate-school-ai\/\" aria-hidden=\"true\" tabindex=\"-1\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\t<img width=\"960\" height=\"510\" src=\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2025\/10\/gtc25-corp-blog-dgx-gb300-1280x680-1-960x510.jpg\" class=\"attachment-medium size-medium\" alt=\"\" aria-hidden=\"true\" loading=\"lazy\" decoding=\"async\"  \/>\t<\/a><\/p>\n<p>\t<a id=\"related-news-post-title-86383\" class=\"full-width-layout__news-post-title\" href=\"https:\/\/blogs.nvidia.com\/blog\/naval-postgraduate-school-ai\/\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\tNVIDIA, NPS Commission the Navy\u2019s AI Flagship for Training Tomorrow\u2019s Leaders\t<\/a><\/p>\n<p>\t\tAlong the Pacific Ocean in Monterey, California, the Naval Postgraduate School (NPS) is making a splash all the way to Washington, D.C.: It\u2019s using artificial intelligence to solve operational challenges&#8230;    <a class=\"read-more\" aria-hidden=\"true\" tabindex=\"-1\" href=\"https:\/\/blogs.nvidia.com\/blog\/naval-postgraduate-school-ai\/\" rel=\"nofollow noopener\" target=\"_blank\">\t\tRead Article            <\/a>\t<\/p>\n","protected":false},"excerpt":{"rendered":"Lilly Deploys Pharma\u2019s Largest, Most Powerful AI Factory for Drug Discovery Using NVIDIA Blackwell-Based DGX SuperPOD | NVIDIA&hellip;\n","protected":false},"author":2,"featured_media":230785,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[554,733,4308,86,56,54,55],"class_list":["post-230784","post","type-post","status-publish","format-standard","has-post-thumbnail","category-artificial-intelligence","tag-ai","tag-artificial-intelligence","tag-artificialintelligence","tag-technology","tag-uk","tag-united-kingdom","tag-unitedkingdom"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/230784","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/comments?post=230784"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/230784\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media\/230785"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media?parent=230784"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/categories?post=230784"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/tags?post=230784"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}